Serum Selenoprotein P Levels in Patients with Type 2 Diabetes and Prediabetes: Implications for Insulin Resistance, Inflammation, and Atherosclerosis | Zendy

Sae Jeong Yang | Zendy; Soon Young Hwang | Zendy; Hee Youn Choi | Zendy; Hye Jin Yoo | Zendy; Ji A Seo | Zendy; Sin Gon Kim | Zendy; Nan Hee Kim | Zendy; Sei Hyun Baik | Zendy; Dong Seop Choi | Zendy; Kyung Mook Choi | Zendy

Open Access

Serum Selenoprotein P Levels in Patients with Type 2 Diabetes and Prediabetes: Implications for Insulin Resistance, Inflammation, and Atherosclerosis

Author(s) -

Sae Jeong Yang,

Soon Young Hwang,

Hee Youn Choi,

Hye Jin Yoo,

Ji A Seo,

Sin Gon Kim,

Nan Hee Kim,

Sei Hyun Baik,

Dong Seop Choi,

Kyung Mook Choi

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-0620

Subject(s) - prediabetes , insulin resistance , selenoprotein p , medicine , type 2 diabetes , inflammation , diabetes mellitus , endocrinology , oxidative stress , catalase , glutathione peroxidase

The dysregulation of hepatokines may be associated with the pathogenesis of insulin resistance and type 2 diabetes. A recent study has suggested that selenoprotein P (SeP), a novel hepatokine, may play a role in the regulation of glucose metabolism and insulin sensitivity. We examined the relationship between circulating SeP levels and clinical parameters associated with insulin resistance in humans.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research